Dacogen (Decitabine) 50mg IV Injection JONSON
Article:
J-3
Interchangeable drugs with the same active ingredient:
dacogen, decitabine
Indications
- Myelodysplastic syndrome (MDS), including treated and untreated, recurrent and secondary MDS of all subtypes.
- Newly diagnosed or secondary acute myeloid leukemia (AML) in patients over the age of 65, according to the WHO classification, is not subject to standard chemotherapy.
-
Commercial name:Dacogen
-
Сhemical name:decitabine
-
Dosage:50 mg
-
Release form:Ampoule
No reviews yet